Author details

Full Name

Chung-Yip Chan

Affiliation

ORCID

Career Start Year

2000

Papers

159

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36857014	Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma.		2023
35837974	Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study.	Annals of Surgery	2023
36354172	Intraoperative blood transfusion does not impact overall and recurrence-free survival after curative hepatectomy for hepatocellular carcinoma: A propensity-score-matched and inverse probability of treatment-weighted study.	Journal of Surgical Oncology	2023
36279983	IFNÎ³IL-17 CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.	Cancer Letters	2023
35999310	Association of standardized liver volume and body mass index with outcomes of minimally invasive liver resections.	Surgical Endoscopy and Other Interventional Techniques	2023
37584601	Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.	Cancer Discov	2023
37094128	Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.	Proc Natl Acad Sci U S A	2023
37069484	Early experience with pure laparoscopic donor hepatectomy: comparison with open donor hepatectomy and non-donor laparoscopic hepatectomy.		2023
36737737	Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.		2023
35139157	Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis.	British Journal of Surgery	2022
36038372	Poor utility of current nomograms assessing the risk of intraoperative blood transfusion in patients undergoing liver resection for hepatocellular carcinoma and proposal of a new model.	Surgery	2022
35644687	A systematic review and network meta-analysis of outcomes after open, mini-laparotomy, hybrid, totally laparoscopic, and robotic living donor right hepatectomy.	Surgery	2022
35382356	Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study.	National Science Review	2022
35692120	Laparoscopic versus open caudate lobe liver resections: a 1:2 propensity score-matched controlled study based on a single institution experience.	ANZ Journal of Surgery	2022
35999856	Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System.		2022
36052580	Limited liver resections in the posterosuperior segments: international multicentre propensity score-matched and coarsened exact-matched analysis comparing the laparoscopic and robotic approaches.	British Journal of Surgery	2022
33569726	Impact of non-liver-related previous abdominal surgery on the difficulty of minimally invasive liver resections: a propensity score-matched controlled study.	Surgical Endoscopy and Other Interventional Techniques	2022
33885021	Short- and long-term outcomes after minimally invasive versus open spleen-saving distal pancreatectomies.	Journal of Minimal Access Surgery	2022
34083386	Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19.	Gut	2022
35301339	Trajectory of immune evasion and cancer progression in hepatocellular carcinoma.	Nature Communications	2022
34508282	Propensity-Score Matched Analyses Comparing Clinical Outcomes of Minimally Invasive Versus Open Distal Pancreatectomies: A Single-Center Experience.	World Journal of Surgery	2022
34972621	Effect of age on the short- and long-term outcomes of patients undergoing curative liver resection for HCC.	European Journal of Surgical Oncology	2022
35184329	Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.	Hepatology	2022
34420824	Impact of tumor size on the difficulty of minimally invasive liver resection.	European Journal of Surgical Oncology	2022
35059983	Minimally Invasive vs Open Major Hepatectomies for Liver Malignancies: a Propensity Score-Matched Analysis.	Journal of Gastrointestinal Surgery	2022
34417027	Impact of introduction of an enhanced recovery protocol on the outcomes of laparoscopic liver resections: A propensity-score matched study.	Surgery	2022
34750608	International multicentre propensity score-matched analysis comparing robotic versus laparoscopic right posterior sectionectomy.	British Journal of Surgery	2021
31680180	Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imaging.	Singapore Medical Journal	2021
31997786	Outcome of minimally invasive liver resection for extrapancreatic biliary malignancies: A single-institutional experience.	Journal of Minimal Access Surgery	2021
34126522	Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: Single institution experience with 1300 resections over 18 years.	Surgical Oncology	2021
33969464	Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.	Annals of Surgical Oncology	2021
34061361	Comparison between short and long-term outcomes after minimally invasive versus open primary liver resections for hepatocellular carcinoma: A 1:1 matched analysis.	Journal of Surgical Oncology	2021
33623020	Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.	Nature Communications	2021
34270940	Non-terminally exhausted tumor-resident memory HBV-specific TÂ cell responses correlate with relapse-free survival in hepatocellular carcinoma.	Immunity	2021
33521877	Preoperative Predictors of Futile Resection of Intraabdominal Extrahepatic Metastases from Hepatocellular Carcinoma.	World Journal of Surgery	2021
33939335	Resected pancreatic adenocarcinoma: An Asian institution's experience.	Cancer Reports	2021
34199580	Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma.	Cancers	2021
33449857	Use of Reinforced Staplers Decreases the Rate of Postoperative Pancreatic Fistula Compared to Bare Staplers After Minimally Invasive Distal Pancreatectomies.	Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A	2021
33719128	Minimally invasive versus open right anterior sectionectomy and central hepatectomy for central liver malignancies: a propensity-score-matched analysis.	ANZ Journal of Surgery	2021
33976720	Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients.	Journal of Cancer	2021
33095920	Actual 10-year survivors and 10-year recurrence free survivors after primary liver resection for hepatocellular carcinoma in the 21stÂ century: A single institution contemporary experience.	Journal of Surgical Oncology	2021
32974782	Impact of liver cirrhosis on the difficulty of minimally-invasive liver resections: a 1:1 coarsened exact-matched controlled study.	Surgical Endoscopy and Other Interventional Techniques	2021
33023824	Validation and comparison of the Iwate, IMM, Southampton and Hasegawa difficulty scoring systems for primary laparoscopic hepatectomies.	HPB	2021
32951861	Impact of Microsurgical Anastomosis of Hepatic Artery on Arterial Complications and Survival Outcomes After Liver Transplantation.		2021
34399972	Use of the Descending Branch of the Lateral Circumflex Femoral Artery as an Arterial Graft in Living Donor Liver Transplant.		2021
34613815	Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.	Sci Transl Med	2021
34775234	Preoperative predictors of early recurrence of AJCC T4 hepatocellular carcinoma.	Surgical Oncology	2021
34644147	Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.	Sci Transl Med	2021
34695377	Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.	Lancet Gastroenterology and Hepatology, The	2021
31499131	Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.	Journal of Hepatology	2020